1. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
   Mikel Rico et al, 2021, World Journal of Clinical Oncology CrossRef
2. Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas
   Stefan Küffer et al, 2022, Cancers CrossRef
3. Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review
   Apostolos C. Agrafiotis et al, 2023, Biomedicines CrossRef
4. Therapeutic options in thymomas and thymic carcinomas
   Yutaka Muto et al, 2022, Expert Review of Anticancer Therapy CrossRef
5. Thymic Epithelial Tumors: An Evolving Field
   Elisabetta Kuhn et al, 2023, Life CrossRef
6. Thymic cancer in lynch syndrome: an unusual association
   Deepali Pandey et al, 2020, BMJ Case Reports CrossRef
7. Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
   Rui Kitadai et al, 2021, Cancers CrossRef
8. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
   Martina Imbimbo et al, 2018, Cancer Treatment Reviews CrossRef
9. Molecular pathology of thymomas: implications for diagnosis and therapy
   Alexander Marx et al, 2021, Virchows Archiv CrossRef
10. Emerging therapies in thymic epithelial tumors (Review)
    Athina Dapergola et al, 2023, Oncology Letters CrossRef
11. The role of targeted therapy in thymic carcinoma
    Mridula Krishnan et al, 2019, Journal of Oncology Pharmacy Practice CrossRef
12. Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas
    Adam Szpechcinski et al, 2022, Cancers CrossRef
13. An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
    Valentina Tateo et al, 2021, Pharmaceuticals CrossRef
14. Thymic epithelial tumours: histopathological classification and differential diagnosis
    Jan von der Thüsen, 2024, Histopathology CrossRef